The Wall Street Journal published Why the FTC Lawsuit over Pay-To-Delay Deals Matters – Carrier Explains, a Q&A with Michael Carrier. Carrier discussed the Federal Trade Commission’s lawsuit, which alleged antitrust violations by Abbott for filing frivolous patent litigation and by Abbott and Teva for entering into a settlement to delay generic entry. Carrier explained the importance of the suit, the issues courts are wrestling with in this area, and what’s at stake for consumers.